Innate Immunity in Atherosclerosis

Similar documents
actually rupture! Challenges to the vulnerable plaque concept

The PROSPECT Trial. A Natural History Study of Atherosclerosis Using Multimodality Intracoronary Imaging to Prospectively Identify Vulnerable Plaque

Pathology of Coronary Artery Disease

The PROSPECT Trial. A Natural History Study of Atherosclerosis Using Multimodality Intracoronary Imaging to Prospectively Identify Vulnerable Plaque

Vulnerable Plaque Pathophysiology, Detection, and Intervention. VP: A Local Problem or Systemic Disease. Erling Falk, Denmark

Imaging Atheroma The quest for the Vulnerable Plaque

Imaging Overview for Vulnerable Plaque: Data from IVUS Trial and An Introduction to VH-IVUS Imgaging

Pathology of Vulnerable Plaque Angioplasty Summit 2005 TCT Asia Pacific, Seoul, April 28-30, 2005

Cottrell Memorial Lecture. Has Reversing Atherosclerosis Become the New Gold Standard in the Treatment of Cardiovascular Disease?

Added Value of Invasive Coronary Imaging for Plaque Rupture and Erosion

Current Cholesterol Guidelines and Treatment of Residual Risk COPYRIGHT. J. Peter Oettgen, MD

Plaque Characteristics in Coronary Artery Disease. Chourmouzios Arampatzis MD, PhD, FESC

Can IVUS Define Plaque Features that Impact Patient Care?

The aorta is an integral part of the cardiovascular system and should not be considered as just a conduit for blood supply from the heart to the

Quinn Capers, IV, MD

Who Cares About the Past?

Η Πυρηνική Καρδιολογία Το 2017 ΟΜΑΔΑ ΕΡΓΑΣΙΑΣ ΑΠΕΙΚΟΝΙΣΤΙΚΩΝ ΤΕΧΝΙΚΩΝ

Assessment of Vulnerable Plaque by IVUS and VH-IVUS

Left main coronary artery (LMCA): The proximal segment

Invasive Evaluation of High Risk or Vulnerable Plaque A Powerful Tool to Address Potential Pharmacological Agents? Jagat Narula, MD PhD MACC

Arteriosclerosis & Atherosclerosis

Review. Reassessing the Mechanisms of Acute Coronary Syndromes. The Vulnerable Plaque and Superficial Erosion

PCSK9 Inhibitors and Modulators

The 10 th International & 15 th National Congress on Quality Improvement in Clinical Laboratories

Ανάπτυξης Ευάλωτων Αθηρωματικών Πλακών

12/18/2009 Resting and Maxi Resting and Max mal Coronary Blood Flow 2

The Changing Epidemiology of Acute Coronary Syndromes: Implications for practice: Dr. Sonia Anand, McMaster University

as a Mechanism of Stent Failure

Vulnerable Plaque. Atherothrombosis

FESC, FACC, MAHA, MSCAI, MEAPSI, ESH

Pathology of the Vulnerable Plaque

Role of apolipoprotein B-containing lipoproteins in the development of atherosclerosis Jan Borén MD, PhD

Assessment of plaque morphology by OCT in patients with ACS

Chest pain and troponins on the acute take. J N Townend Queen Elizabeth Hospital Birmingham

Report For Center Created Gender D.O.B Page 1 Sean Breen HeartSmart IMT plus 3/29/2012 Male 11/26/1973 B C D E

Davos Mechanisms of ACS: the clinical perspective. Filippo Crea Institute of Cardiology Catholic University of the Sacred Heart Rome, Italy

Invasive Coronary Imaging Modalities for Vulnerable Plaque Detection

Cardiovascular Research Foundation and Columbia University Medical Center, New York.

Blood Vessels. Dr. Nabila Hamdi MD, PhD

HARVARD MEDICAL SCHOOL

The Future of. Cardiac Biomarkers

STABILITY Stabilization of Atherosclerotic plaque By Initiation of darapladib TherapY. Harvey D White on behalf of The STABILITY Investigators

HEART HEALTH WEEK 2 SUPPLEMENT. A Beginner s Guide to Cardiovascular Disease ATHEROSCLEROSIS. Fatty deposits can narrow and harden the artery

Causes of death in Diabetes

Atherosclerosis, inflammation and leukotrienes

Usefulness of OCT during coronary intervention

Inflammation: Novel Target for Cardiovascular Risk Reduction

Ischemic heart disease

Intervention: How and to which extent is technology helping us?

Can We Identify Vulnerable Patients & Vulnerable Plaque?

Cardiovascular Division, Brigham and Women s Hospital, Harvard Medical School

Acute Coronary Syndromes Compendium. Acute Coronary Syndromes: Pathology, Diagnosis, Genetics, Prevention, and Treatment

Mechanism: How ADT accelerates CVD?

INFLAMMATION &THROMBOSIS INSIGHTS FROM CANTOS TRIAL AHMED NADA, FSCAI ALMOSTAKBAL HOSPITAL, JEDDAH SAUDI ARABIA

Conflicts of interest. Very balanced Lilly and team, AZ and BMS

Spotty Calcification as a Marker of Accelerated Progression of Coronary Atherosclerosis : Insights from Serial Intravascular Ultrasound

CARING FOR A LOVED ONE AFTER A HEART ATTACK OR STROKE

Lipid Lowering in Patients at High Risk for Cardiovascular Disease

High-risk vulnerable plaques. Kostis Raisakis G.Gennimatas General Hospital of Athens

From the Vulnerable Atherosclerotic Plaque to CAD Management

Best Lipid Treatments

CT Imaging of Atherosclerotic Plaque. William Stanford MD Professor-Emeritus Radiology University of Iowa College of Medicine Iowa City, IA

1st Department of Cardiology, University of Athens, Hippokration Hospital, Athens, Greece

Prevalence of Coronary Artery Disease: A Tertiary Care Hospital Based Autopsy Study

Fasting or non fasting?

ATHEROSCLEROSIS زيد ثامر جابر. Zaid. Th. Jaber

Basic Mechanisms of Atherosclerosis and Plaque Rupture: Clinical Implications

CHAPTER 45 Unified Model: Intersection of Lipoproteins and Dysfunctional Clones of Smooth Muscle Cells

Acute Coronary Syndrome. Cindy Baker, MD FACC Director Peripheral Vascular Interventions Division of Cardiovascular Medicine

Vascular disease. Structural evaluation of vascular disease. Goo-Yeong Cho, MD, PhD Seoul National University Bundang Hospital

Inflammation and and Heart Heart Disease in Women Inflammation and Heart Disease

SEX LIES CHOLESTEROL

Clinical Study of Lipid Profile Pattern in Acute Coronary Syndromes

Dyslipidemia 울산의대서울아산병원심장병원심장내과이철환

04RC2. The biology of vulnerable plaques. Jozef L. Van Herck 1, Christiaan J. Vrints 1, Arnold G. Herman 2

IMMATURE PLATELETS CLINICAL USE

Platelet Neutrophil crosstalk in thrombotic disorders Dimitrios A. Stakos

Catch-up Phenomenon: Insights from Pathology

Adults With Diagnosed Diabetes

Of the 1.5 million heart attacks

Le espressioni della placca che preoccupano il clinico: progressione o vulnerabilità? CardioLUCCA Marzo 2017

TVA_C02.qxd 8/8/06 10:27 AM Page 19 PART 2. Pathology

New Frontiers in Atherosclerotic Disease and Myocardial Infarction: From local inflammation to systemic stem and progenitor cell reaction

CHAPTER (2) THE VULNERABLE PLAQUE

Stable Ischemic Heart Disease. Ivan Anderson, MD RIHVH Cardiology

Pathophysiology of Cardiovascular System. Dr. Hemn Hassan Othman, PhD

ARE YOU AT RISK OF A HEART ATTACK OR STROKE? Understand How Controlling Your Cholesterol Reduces Your Risk

VasoRx: Atherosclerotic Plaque Regression

Statin pretreatment and presentation patterns in patients with acute coronary syndromes

CLINICAL APPLICATIONS OF OPTICAL COHERENCE TOMOGRAPHY. Konstantina P. Bouki, FESC 2 nd Department of Cardiology General Hospital Of Nikea, Pireaus

Continuing Medical Education Post-Test

Non-invasive Plaque Imaging

PATHOPHYSIOLOGY OF ACUTE CORONARY SYNDROMES

The Case for Intravenous EDTA Chelation Therapy, August, 2006 update.

Balancing Efficacy and Safety of P2Y12 Inhibitors for ACS Patients

Inspired Functional Ingredients to Innovate and Differentiate Your Brand. Products by Ecovatec Solutions Inc.

Hans Strijdom SA Heart Meeting November 2017

Coronary Artery Calcium Score

Pathology of percutaneous interventions (PCI) in coronary arteries. Allard van der Wal, MD.PhD; Pathologie AMC, Amsterdam, NL

Transcription:

Innate Immunity in Atherosclerosis Peter Libby Brigham & Women s Hospital Harvard Medical School IAS Amsterdam May 26, 2015

ACS Stable demand angina Characteristics of Atherosclerotic Plaques Associated with Various Presentations of Coronary Artery Disease Libby P. N Engl J Med 2013;368:2004-2013 ACS

n engl j med 368;21 nejm.2004 org may 23, 2013 MMP = matrix metalloproteinase N Engl J Med 2013;368:2004-13.

We tend to face today s battle prepared to fight the last war Is the vulnerable plaque a valid concept in 2015?

Challenges to the vulnerable plaque concept Few thincapped plaques actually rupture!

Stone GW et al. N Engl J Med 2011;364:226-235 Only 5% of thin-cap fibroatheromas cause events at a median follow-up of 3.4 Years (PROSPECT) Thin-cap fibroatheromas (TCFA) Minimal luminal area (MLA) Plaque burden (PB)

Challenges to the vulnerable plaque concept The character of human plaques is changing in the statin era

Human plaques are getting less fatty in the statin era Human plaques are getting less inflammmed in the statin era van Lammeren et al. Circulation. 2014;129:2269-2276.

The character of human plaques is changing Statin use is on the rise

ACS Treatments Changing with Time Dual anti-platelet Rx ASA b-blockers Statins ACE-I or ARB Swedish Registry:Hospital Survivors Receiving Specific Medications Jernberg et al. JAMA 2011;305:1677-1684

Previous Use of Medication on an Outpatient Basis Population Trends in the Incidence and Outcomes of Acute Myocardial Infarction. Yeh RW et al. N Engl J Med 2010;362:2155-2165

Challenges to the vulnerable plaque concept The risk profile and demographics of ACS patients is shifting worldwide (global burden, younger patients, more women, more insulin resistance/diabetes, more hypertriglyceridemia, less LDL excess) Statin treatment and other preventive measures have begun to modify atherosclerotic disease

The Changing Face of the Acute Coronary Syndromes What mechanisms beyond plaque rupture may contribute to the residual burden of events in the current era?

ACS Stable demand angina The Acute Coronary Syndromes are Changing Before Our Eyes Fewer STEMI, more NSTEMI Less rupture, more erosion? Libby P. N Engl J Med 2013;368:2004-2013 ACS

The Changing Face of the Acute Coronary Syndromes Is innate immunity involved in superficial erosion?

Potential mechanisms of plaque erosion Plaque erosion associates with disturbed flow Tricot et al, Circ, 2000

Potential mechanisms of plaque erosion Biomechanics, proteoglycan, and hyaluronan in erosion Lee et al. JBC, 2001 Koloddgie et al. ATVB 2002

Potential mechanisms of plaque erosion Hyaluronan and TLR2 function in endothelium under disturbed flow in atherosclerosis Ascending aorta LDLr-/-TLR2-/- LDLr-/- Chow Diet CD31 TLR2 HFD 4 weeks CD31 TLR2 TLR2 CD31 Scheibner et al, Jimmunol, 2006 Mullick et al, JEM, 2008

Hyaluronan promotes endothelial apoptosis and inflammation Quillard et al. EHJ, 2015 HA: Hyaluronic acid

Potential mechanisms of plaque erosion TLR-2 agonists stimulate endothelial cell inflammatory functions Quillard et al. EHJ, 2015

TLR2 LIGATION AND NEUTROPHILS IMPAIR ENDOTHELIAL ADHERENCE Quillard et al. EHJ, 2015

TLR2 agonists retard repair of wounded monolayer of human endothelial cells 10h 0h ctrl LTA Pam3 Quillard et al. EHJ, 2015

Activated ECs can induce nets and become susceptible to NETosis-mediated cell death Neutrophil extracellular traps (NETs) Fuchs et al, ATVB, 2012

Do NETs associate with human plaques with features of erosion?

Human plaques with erosion characteristics associate with NETS «Stable» «Erosion-prone» «Rupture-prone» Neutrophil elastase Citrullinated histones Quillard et al. EHJ, 2015

EC apoptosis associates with luminal PMNs and TLR2 expression only in SMC-rich lesions Quillard et al. EHJ, 2015

Neutrophils localize in erosion-like lesions DNA Neutrophil elastase Citrullinated histones Quillard et al. EHJ, 2015

Neutrophil Extracellular Traps (NETs) in Human Atherosclerotic Plaques Quillard et al. EHJ June 2015 DNA Citrullinated histone Neutrophil elastase

The frond-like processes extending into the lumen from the intimal surface of a human carotid atheroma exemplify neutrophil extracellular traps (NETs) derived from DNA extruded by dying granulocytes. This merged immunofluorescent micrograph shows neutrophil elastase (green), citrullinated histone-4 (red), and nuclei (blue). See figure legend on page 0000.

The innate immune receptor TLR2 promotes endothelial functions related to superficial erosion. Quillard et al. EHJ 2015

Implication of the Innate Immune Receptor TLR2 in Plaque Superficial Erosion Promotes endothelial (EC) death Promotes EC desquamation Impairs EC monolayer healing Sets the stage for formation of neutrophil extracellular traps

The Changing Face of the Acute Coronary Syndromes Superficial erosion may be on the rise Innate immunity may drive superficial erosion